I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
MiR-140 leads to MRE11 downregulation and ameliorates oxali..:
Josef Horak
;
Alexandra Dolnikova
;
Ozge Cumaogullari
...
https://www.frontiersin.org/articles/10.3389/fonc.2022.959407/full. , 2022
Link:
https://doi.org/10.3389/fonc.2022.959407
RT Journal T1
MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:3522c5a78afe4cca8e6b702e06abe405&Exemplar=1&LAN=DE A1 Josef Horak A1 Alexandra Dolnikova A1 Ozge Cumaogullari A1 Andrea Cumova A1 Nazila Navvabi A1 Ludmila Vodickova A1 Miroslav Levy A1 Michaela Schneiderova A1 Vaclav Liska A1 Ladislav Andera A1 Pavel Vodicka A1 Alena Opattova PB Frontiers Media S.A. YR 2022 K1 miR-140 K1 colorecal cancer K1 MRE11 K1 oxaliplatin K1 therapy response K1 DNA damage K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2022.959407/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.959407 DO https://doi.org/10.3389/fonc.2022.959407 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)